InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Tan Kevin, Chief Financial Officer. Insider active across 1 companies, notably Selecta Biosciences INC. In total, 4 disclosures have been recorded. Total volume traded: €27k. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
072,000 shares0
Common Stock
SEC:0001453687-22-000024·
072,000 shares0
Common Stock
SEC:0001453687-22-000024:0·
€13,3635,000 shares@ €2.6726100.0% of flow
Common Stock
SEC:0001453687-21-000164·
Ideal exit: 29 Aug 2022 (T+270)
€13,3635,000 shares@ €2.672650.0% of flow
Common Stock
SEC:0001453687-21-000164:0·
Ideal exit: 29 Aug 2022 (T+270)
4 of 4 declarations
About Tan Kevin
Kevin Tan is the Chief Financial Officer of Selecta Biosciences Inc. He is responsible for the financial management of the company, including budgeting and financial reporting. His expertise in finance is essential to support the growth and sustainability of the organization.
